Kinnevik AB
STO:KINV B
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
60.9657
106.02
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Good morning, and welcome to the presentation of Kinnevik's results for the second quarter in 2022. I'm Georgi Ganev, Kinnevik CEO; and with me today is our CFO, Erika Söderberg Johnson; our Chief Strategy Officer, Samuel Sjostrom; and our Director of Corporate Communications, Torun Litzen.
Let's move to Page 2 directly. The sharp market downturn we have seen during 2022 will likely have deeper economic effects than we expected 6 months ago. Rising interest rates to combat higher inflation has caused valuation multiples for growth companies to contract considerably. An economic recession in our key geographies is the next likely step. And combining this with a tougher fundraising environment has caused extreme pressure on cash-consuming growth companies. Ultimately, this may have a material negative impact on some of our less resilient companies. But that said, I am confident that Kinnevik will, over the long term, emerge from this downturn as a stronger company and regard the current downturn as a net positive for two reasons.
Firstly, we have allocated capital in a structured and disciplined manner in the last few years of elevated valuations. In addition, we have built a balanced portfolio of companies at different stages of maturity and time to profitability. Secondly, our permanent capital and strong financial position means we can take a more long-term view than many other investors. We can support and guide our strongest companies through the downturn and also have ample firepower to seize opportunities that will arise from this crisis.
On this call today, I will begin by commenting on our net asset value development and then go through the key events of the quarter. After that, we will spend some time on the composition of our growth portfolio, which we think is significantly more balanced and robust than it was 2 to 3 years ago. Erika will then guide you through the key valuation changes during the quarter. And finally, our view on our capital reallocation through this environment.
Now moving to Page 3. At the end of the second quarter in 2022, our net asset value amounted to SEK 61.1 billion or SEK 218 per share. That's down by SEK 6.7 billion or 10% compared to the end of the first quarter. We have effectively written down each individual unlisted investment by around 30% on average this quarter. However, the reported fair value of our unlisted portfolio decreased by a more muted 7%. And it's important for you to understand why this is the case. And Erika will speak to you about that in more detail in a few minutes. But in short, our substantial write-downs have been cushioned by a handful of transactions in Q2, our liquidation preferences and material currency tailwinds. Adding to that, our companies are outpacing their peers, growing their revenues by more than 135% year-on-year in the first half of 2022.
Now on this page, let's now focus on the highlights of the quarter. We made follow-on investments in Budbee and Mathem, and I will get back to Budbee in a minute. This is not easy in this environment to raise capital, and it's a real sign of strength from both these companies. In May, we divested around 1/4 of our shares in Tele2 for SEK 6 billion. The proceeds from this transaction, together with the dividends received from Tele2, brought our net cash position to SEK 13.6 billion by end of June. This provides us with additional financial strength at a time of market uncertainty and ensures we have a net cash runway through 2024. It also gives us increased flexibility to be forward-leaning when attractive opportunities arise.
Finally, we continue to drive the development in our industry with regards to our sustainability initiatives. We published our first Climate Progress Report last week, and I will talk about this more later. But the results presented in this report proves that with clear strategies and targets, you can make a real impact.
Now moving to Page 4. As I mentioned earlier, in recent years, we have made strides in building a balanced portfolio with companies spread across the S-curve in terms of growth and time to profitability. We have achieved this by investing at different stages of maturity as well as making consistent follow-on investments to fund continued growth in our most promising businesses. In addition, many of our companies took advantage of the strong market of the past by raising capital and extending their runways.
Taking our company's differences into account, we evaluate each situation individually and do not push any generic advice and how they should value growth versus profitability in the short term. This page shows some illustrative examples from our portfolio of companies on the S-curve.
On the right-hand side, you see job and talent, which we invested in late last year. The company grew revenues by 130% in 2021, while being profitable at an EBITDA level. Now the other side of the S-curve, we have Omnipresent, which we invested in just a few months ago and which is at a significantly earlier stage of growth. In 2021 alone, the company grew revenues by 25x. And in the middle, we have an example of a company that has successfully moved along the S-curve, Budbee. I would like to dive a bit deeper into Budbee on the following page.
Since we first invested in Budbee in 2018, the company has grown revenue by 20x and was also profitable in its underlying operations in 2021. During these first 4 years, we have continued to consistently invest more capital into the business to support its continued profitable growth. Our first investment in Budbee has to date generated a return of 11x. And in total, our investments in Budbee has returned 4.4x our aggregated invested capital. And in May, Budbee completed a funding round that was oversubscribed. This is a great example of how high-quality companies still can raise capital at attractive terms even in these markets. And another key milestone is the contract in the Netherlands, which includes the installation of parcel lockers and 700 Albert Heijn stores. We very much look forward to continuing supporting Fredrik Hamilton, the founder of Budbee, and the entire Budbee team on a successful growth journey.
Let's now move to Page 6. I always talk about our sustainability efforts with great pride, and I felt that, particularly when we released our first climate progress report in June. Climate change is one of the greatest challenges of our time. And as an investor, Kinnevik has a unique position to influence our companies to become climate leaders. And in 2021, our companies that report emissions decreased their emissions intensity by 11%. This means we reached our annual target of 7% by a wide margin. It also means that we reached the annual climate sustainability performance target for our outstanding sustainability-linked bonds. This is the key to decarbonization, to decouple economic growth from emissions growth. Our long-term target is to achieve a 50% reduction in emissions intensity across our portfolio by 2030. And reaching this target is important to us for many reasons, not least because aligning our portfolio with a low carbon future opens massive opportunities that we want our companies to take advantage of.
Now I would like to hand over to Erika for a more detailed description of the key valuation changes during the quarter and our perspective on capital allocation in this environment.
Thank you, Georgi. As mentioned, there have been a handful of transactions that guide our valuations this quarter such as Budbee and Mathem as well as Omio. Including the valuations of these companies, the average write-down was around 20% on an underlying basis. Putting these transaction in fee valuations aside, the average write-down instead exceeded 30%. This is fairly in line with how our company's public benchmarks have traded in the quarter.
Then, how come the write-down of our unlisted assets only adds up to 7% in total? Two reasons: liquidation preferences and currencies. In total, these two factors contributed with an approximate SEK 3.6 billion positive effect in the quarter. I will get back to these two factors in a second, but let's first talk about the most important value drivers, multiples and underlying operational performance.
Flipping ahead to Page 8. We wanted to make sure you understand that we are not being gentle when it comes to superimposing public market multiple compression on our unlisted companies. As illustrated on the left-hand chart, we have contracted the multiples in our unlisted portfolio on par with peer groups pretty much across all sectors. In aggregate, we have contracted our multiples by around 43% on average during '22.
We have been more gentle on our software investments, compressing multiples by around 40% year-to-date rather than the 60% observed in the peer groups. Why? Because the peer group is weighed down by the reversal of sectoral trends in areas like e-commerce, whereas our key investments, Pleo and TravelPerk, are inversely enjoying material tailwinds on the back of pandemic-induced restrictions waning off. This, we believe, warrants a more moderate approach than that we have seen in companies like Shopify.
On the right-hand chart, we are showing the difference in revenue growth between our analyst companies and their public benchmarks. The chart probably speaks for itself, but to give you an aggregate number, our investees outpaced their public peers by 4.5x on top line in the first half for '22, growing revenues by more than 135% year-on-year relative to a more modest 30% for the public peers win for multiples from.
The mood music may have shifted towards profits for the time being, but considering our companies are generating gross profits -- gross margins on par with their listed peers, we believe this material overperformance on growth warrants higher short-term revenue multiples for some of our businesses, provided they have the ability to continue to overperform at these kind of levels.
With that, let's move on to Page 9. As mentioned, liquidation preferences and the currency tailwind provided a positive SEK 3.6 billion effect in the second quarter. The same number for the first half of '22, amounts to SEK 4.4 billion. Stripping out this effect, the change in fair value of our unlisted portfolio would be down by more than 30% year-to-date rather than the roughly 16% shown in our reported numbers.
I trust you're all aware of what has happened with the Swedish krona during '22, so let's focus on liquidation preferences. Liquidation preferences are highly customer provisions in early-stage investing. In general terms, these types of provisions affect how value is allocated between shareholders in an exit or IPO. The most common type of liquidation preferences entails that in case the company is sold or listed, a valuation below the valuation in the last private funding round, investors are guaranteed to get at least their invested capital back. It also means that as long as the valuation is higher than the amount of capital the company has raised, investors are equally guaranteed to get their money back. As you can imagine, this causes inertia in the fair values of our investments when we write down investments that have been carried at marks in line with the capital we have invested. As a result, the effect of these preferences are typically centered around the new investments we've made in '21 and early '22, where our fair value is unchanged but our assessment of the underlying valuation of each relevant company may have lowered materially. This is not a theoretical concept. These types of provisions have been enforced in numerous exits and IPOs that we have undertaken historically and are very much an economic reality.
Clearly, we are not sellers of all these assets at currently prevailing valuations, but our regulatory framework requires us to value our investments at the price that we would receive when selling it. And that price is at times determined by these types of provisions. This is why we take them into account in our NAV statement.
The aggregate effect of these provisions per end of June amounts to SEK 2.4 billion in current exchange rates. The SEK 2.2 billion illustrated in the chart on the right-hand side is the effect in constant currencies year-to-date. This means that without these provisions, our fair values would be SEK 2.4 billion lower. Conversely, if you were to make forecasts on upside of our NAV, you should start from a SEK 2.4 billion lower base.
With that, let's move on to Page 10 and some of the key valuation reassessments among our unlisted assets in the quarter. As covered before, almost all of the valuation changes in the period are in the red, but there is one material exception, Budbee. As Georgi mentioned earlier, the company raised SEK 400 million in the quarter to support the growth. And this is also what underpins our valuation increase of more than 40%. We value the business at SEK 7.3 billion, which corresponds to a premium of around 50% to its key listed peer impose on an NTM basis. The premium is justified by Budbee's exceptional growth rate, which is almost 4x that of its peer as well as its proven underlying profitability at group level.
Moving on to Pleo, which fair value write-down is the largest in absolute terms among the private companies due to the high value of our stake, courtesy of the company's fantastic progress. The NTM multiple used in valuing the business has contracted by 35% in the quarter. As mentioned, this is slightly more modest than the peer set, considering Pleo benefits from the ongoing reversal of consumer behavior coming out of the pandemic, a reversal which is impacting the peer group adversely. The company is also growing around 4x faster than its peers.
Moving on to our 2 most important investments in value-based care, namely VillageMD and Cityblock. The valuation of VillageMD is more than 30% below the valuation in their transaction with Walgreens in Q4 last year in dollar terms, but benefits from FX tailwinds. Year-to-date, VillageMD's NTM multiple has contracted by almost 50%, which is 5 percentage points more than the average peer. We value the company at the premium compared to peers on an NTM revenue basis as VillageMD is growing more than twice as fast as the peers. This outperformance also makes this premium to narrow considerably or even turn into a discount when looking into 2023 and onward.
Cityblock is written down by another 12% in the quarter. And year-to-date, the asset is down 25% in SEK terms or 35% in dollar terms. Year-to-date, the contraction in our NTM revenue multiple used to assess Cityblock's fair value amounts to more than 50%, almost 10 percentage points deeper than the average peer. Similar to VillageMD, the company catches up with the peer group, pushing the revenue base 6 to 12 months further into the future as Cityblock is outgrowing its peers by 2x.
Turning to the next slide, Page 11. Overall, our NAV is down by SEK 6.7 billion or 10% in the quarter and amounted to SEK 61.1 billion at the end of June. After the sell-down of Tele2 of SEK 6 billion and receiving another [ SEK ] 3.1 billion in dividends, our net cash position of SEK 13.6 billion corresponds to 28% of portfolio value.
As in the last 2 quarters, Tele2 was more resilient than our growth assets. Our listed growth companies, Babylon, Teladoc and GFG were down by around 50% or SEK 2.9 billion. As covered previously, the valuations of the unlisted assets continued to be under pressure, but needs to be unpacked to be understood. So in short, valuations supported by transactions taking place in the second quarter, thereby priced in the current valuation environment gave a positive effect of SEK 1 billion. The write-down of unlisted assets not transacted in the second quarter amounted to SEK 3.2 billion. And as mentioned earlier, excluding liquidation preferences and currency tailwinds in the quarter, the fair value of our unlisted growth portfolio would have been SEK 3.6 billion lower.
With that, let's move on to Page 12. We had a SEK 13.6 billion net cash position at the end of June and still expect to invest around SEK 5 billion in full year 2022, split approximately equally between new investments and follow-ons in our existing portfolio. And on follow-ons, in the center of this page, we have provided you some indications as to the runway of our unlisted portfolio. By fair value, around 9% of our companies have runway ending this year and will be forced to raise in this difficult environment. But more than 1/3 of our companies have runway lasting until the second half of 2023, and almost half of our companies have runway into 2024 or beyond. Our and our investee's financial strength clearly adds to our sense of confidence in allocating capital in this environment. It is also why we feel we have great degrees of freedom as to the timing of our capital deployment and that we will be able to pounce on opportunities as and when they arise. In any case, even without a single inflow of capital over the coming 2 years, we will be more than able to maintain a SEK 5 billion annual investment momentum.
With that, I would like to hand back over to Georgi for some closing remarks.
Thank you, Erika. As I said at the beginning, I believe the pressure that we've seen on growth valuations will continue, and it will be soon clear which companies rose with the tide during the pandemic and which truly have the potential to become long-term successful. This is the case for the vendoring growth market in general as well as for us at Kinnevik.
It's important to remain humble in this environment. But that said, I think Kinnevik is in a very good position to emerge from this crisis as a stronger company with a long-term view, our balanced portfolio and our strong balance sheet. That said, we are now ready to answer your questions. So operator, please open up for Q&A.
[Operator Instructions] Our first question comes from the line of Derek Laliberte from ABG.
So you mentioned in your outlook statement that we will see a greater negative effect going forward here in the companies that are less resilient, which makes a lot of sense. I mean, have you generally made bigger valuation cuts would you say in this names than indicated by the peer valuations? And have you also adjusted your own revenue estimates, et cetera, for these companies due to this macroeconomic outlook factors?
Yes. I think -- I mean, looking at our valuation methodology, of course, we take into consideration the outlook for the company. And what's shown in their forecasts and budgets and all the actions they are taking. So companies that are less resilient to the changes we see in the market, companies that have a kind of shorter runway and/or are less kind of adaptable to situations like this are therefore, let's say, written down at a greater extent.
Okay. And secondly, I was wondering, looking at the report here, I might have got this wrong, but it appears that you have raised your revenue estimates by quite a bit here for the coming 12 months. Can you sort of give any flavor on which companies are performing better than expected comparing to 1 quarter ago?
Sorry, Derek, just to make sure, are you referring to the value drivers waterfall on Page 30? Or are you thinking about sort of the delta and the descriptive tables compared to the Q1 report?
Yes, exactly. It just seems when looking at sort of the multiples and the valuations here that sort of on aggregate for the different segments here that the overall sort of impact from a greater revenue base and the multiple here has had a positive impact. And I assume you're moving 1 quarter forward so to be in the next 12 months here. But it just seems that the sales estimates are up for 2022 compared to before.
To your point. I think in the last quarter, in that table, we had full year 2022 multiples, right? And now we show you NTM. So the base is pushed 6 months forward. As Erika mentioned, our companies grew by more than 135% on average in H1. So clearly, that revenue base increases when you move forward a few months. But it's not sort of -- it's not us raising estimates in terms of sort of where our companies will be financially over the coming years. It's just a matter of moving forward in time.
Okay. Yes, I have a bit trouble here. But I presume there so -- there are no major changes, I suppose, in sort of your underlying estimates for the companies on an overall basis, that is.
Yes. But it's -- just to be clear, it's actual growth figures in H1. So when the windows moved forward to NTM, those growth figures are taken into account into that period. Therefore, they are greater than before, right? But there -- it's not the estimates that are changed. You can say that our company have been growing faster in H1 than before.
Yes. Sorry, I just -- seems the line on the phone after talking to the telephone. It's just the audio is better on the webcast than on the phone. Regardless on the -- I was wondering also, you mentioned the downside protection provisions here. Could you mention which companies are affected by this. I found them [indiscernible] and job and talent in the report that you had a comment. Are there any other benefited [indiscernible] from this?
I think if you sift through Note 4 in the report, Derek, you'll find sort of the company by company disclosures as far as we're comfortable. In addition to that, I also think we mentioned that it's largely centered around the more recent investments where we've only participated in 1 round where you haven't sort of seen any write-ups since that investment. Clearly, those are more affected by these types of downside protections rather than the companies that we have written up through COVID.
Okay. And finally, from my side, just looking for an update on -- you have this total shareholder return target of 12% to 15%. How is that linked to this sort of split between listed and unlisted assets because I would generally think that now that you're share of unlisted assets in the portfolio has increased by quite a bit that this would somehow impact the return targets?
Yes, as said before, the more -- the larger the share of unlisted assets and more sort of high-risk assets, the higher our return requirements gets. So as we said, we will -- we are constantly evaluating and we will revisit when the portfolio has moved along so that the underlying requirements for the composed portfolio has increased. It's not something we've done yet, but as we said several times, this is something that will most likely happen as our companies, even if they move along the S-curve, the share of unlisted growth companies have increased when we decreased the number of listed sort of value companies.
Our next question comes from the line of David Johansson of Nordea.
So we have seen quite large changes in the tech and DC space recently from companies announcing cost savings measures and reducing headcount numbers, also with increased focus on profitability over growth. So maybe you could comment on the operational development and revenue growth in some of your holdings. For example, we saw Babylon announcing cost-cutting actions last week. Have you initiated similar cost savings measure in some of your other companies?
David, thank you for the question. So first of all, I would like to say that we try not to have kind of 1 common recipe for all our businesses in the portfolio. It depends, I mean, how close they are to profitability, what's the kind of overall efficiency, what's the runway and so forth. But as you rightly pointed out, Babylon has announced this cost-cutting to extend the runway and also focus more on profitability.
I mean, I think when they became a public market, the only thing the market asked for was growth. And they did impressively grow the market -- the revenue by 3.5x last year and almost 4x the first quarter of this year. Now the focus is to turn that growth into profits, maybe a little bit sooner than they initially planned.
The important thing to say here as well is that we see that roughly 50% of our unlisted assets are financed with a runway that lasts at least to 2024 or through 2024 or to profitability and less than 10% has a runway that ends this year. And of course, some companies will have to take more kind of cost-cutting actions than others, but I don't want to go into specific company details.
Very clear. Another question. So I noticed you stopped reporting now for an investment to raise in DS, which you've held for quite some time. Maybe you could tell us what the reason for this is? Surely, this is not one of your newer investments.
Sure. It's fairly simple. After the write-down that we're doing this quarter, they make up such a miniscule share of our NAV. So we don't feel necessarily that's worthwhile to point any attention to it. I think it's also -- it's not only sort of the smallest stake in terms of percentage of NAV, but it's also at least one of the smallest in terms of percentage ownership. So it's sort of -- it's noncore, and that's why we're moving it out.
Okay. Fair enough. So last one from my side. So liquidation preferences at quite a bit of cushion for NAV in Q2, and it was significantly higher than in the first quarter. What's the reason for high this? And how should we think about liquidation preferences going forward?
Sure. The reason behind it is fairly simple. That's us writing down our underlying companies quite significantly this quarter, as Erika told you about. I think the way you guys should think of it, I mean, you typically have your 12-month horizons and hopefully, you try to find some upside during that time period. You should effectively, and I also think Erika had mentioned this during the presentation, just remove SEK 2.4 billion from your base when you sort of calculate upside. If you guys want to try and forecast downside, that's going to be a lot more tricky and very sort of dynamic in terms of what companies you're looking to revise your sort of forward-looking valuations for. But there will continue to be inertia on downside here on out. But again, if you want to calculate downside, then just remove the SEK 2.4 billion from your base.
Our next question comes from the line of Oskar Lindstrom at Danske Bank.
Yes. Just first off, I have a bit of a hard time hearing you over the phone. The webcast on the web is much better, but just to be aware that this -- I might have trouble hearing your answers. First off, is just a question, you write in your CEO comment here that you are focused on supporting your most promising companies throughout this downturn. And then you also show that sort of half of your unlisted portfolio has a runway of 1.5 years. I mean, do you see a scenario where you will be -- start to be more selective in which unlisted assets you are willing to reinvest in and perhaps exiting some of these assets or not reinvesting in them?
I hope you hearing now. We're using a different microphone now. But I'll try to answer your question. Obviously, I mean, when we invest in a company, we have high conviction, right? And as we see more and more proof points in that conviction increases, we're starting to build up a relationship with management, the founder and hopefully, some co-investors and we see proof points we want to follow on with more investments.
But as for the market in general, some of the businesses in the portfolio will be less resilient or we might have misunderstood the companies or the thesis that we had initially. And if that happens, we might not actually deploy capital, although we have a strong balance sheet. So we are ready to invest in the companies where we have the long-term belief. But that doesn't mean that we necessarily need to invest in all companies in our portfolio.
All right. I have a second question, if I may? I mean you commented here that in the sort of uncertain market -- sorry, you sold off the Tele2 shares. I mean if this uncertain market environment remains and -- or perhaps if you see new investment opportunities, would you see a need to sell off more or be willing to sell off more Tele2 shares as a source of financing?
I mean with a net cash position end of June of more than SEK 13 billion, we feel that we have a very strong balance sheet right now. And as Erika said, we are guiding around SEK 5 billion this year, which is the average of what we have invested over the last few years and more or less equally split between new and follow-on investments. So I think we are ready to seize the opportunities in the market, and we're ready to back kind of the winners in our portfolio. So there is no other decision taken.
But of course, it feels good as well to have a portfolio that is balanced. So just within the growth portfolio, as you saw in the presentation, we have companies more or less evenly distributed along that S-curve, which means that some of them are close to profitability and some are much early in the journey. And then we have, of course, on top of that, Tele2, which is a stable value stock, which is, of course, good to have in times like this.
And our next question comes from the line of Rasmus Engberg of SHB.
I also had a really hard time answering the questions, but can I -- or hearing the questions really. The question about the liquidation preference effects, would that be larger or smaller in the coming quarters, according to your best guess right now?
I hope you can hear me now. We do not provide any guesses as to the effect of liquidation preferences going forward. If we continue to write down assets, then it's likely that, that effect will be higher. If we see sort of a reversal of the last 2 quarters' trend, then the effect will become smaller.
Right. Okay. And then the question -- the final question for me is your share -- you said was that Budbee was oversubscribed. But your share -- your ownership percentage-wise in Budbee and Mathem are still unchanged, right? So you took your share of the equity issues. Is that correct?
That's correct. We took our pro rata of that round.
Right. Okay. So you didn't really sort of think that despite the high demand, you didn't take down your share in Budbee is that...
No, I think we have very strong conviction in Budbee, but we own also quite a lot of the company, a bit less than 30%. So we think that's a good exposure. So pro rata felt like the best decision for us at that time.
And we have one further question in the queue at this time. That's from the line of Joachim Gunell at DNB Markets.
So just 2 final questions from my end. Can you comment anything on -- or with regards to your view on the attractiveness of share buybacks. I mean, I know that you have a portfolio to support in terms of funding. But based on the fact that it's a quite sizable net cash position, it's well -- it well takes into consideration the capital allocation framework you have for, say, the coming year, at least. And what IRR hurdles you want to see in order to conduct share buybacks?
Joachim, thank you for your question. So I think, I mean, with our strong net cash position of SEK 13.6 billion, end of June, we, of course, have a lot to think about when it comes to deploying capital. But I think in terms of order of priority, we would firstly like to see companies in our portfolio to pursue opportunities to invest in the market, and we would like to support them doing so. So invest specifically in the companies we have a very high degree of conviction.
Secondly, of course, we're also looking at new opportunities in the market. We believe that although it's a difficult market out there, this could mean that there are great opportunities for us to invest in new businesses. And there are also new exciting sectors that we are currently working on.
And then thirdly, of course, if we see no opportunities within our portfolio or out there when it comes to new investments, then the kind of third priority would be to consider buying the entire portfolio, which is effectively what we will do if we do the buybacks. But I think that's a more theoretical scenario since our view right now is that we see great opportunities and great companies, both within our portfolio and out in the market. So buybacks is nothing that we have planned.
Understood. And with regards to new or follow-on investments in your existing holdings, can you just help us understand here the trade-offs that, okay, we entered this phase now where private market valuations could be a bit more stale than public ones, obviously. But I mean, if you are really long term, perhaps it would make sense to actually make a follow-on investments -- I mean in down rounds to secure, I mean, the highest potential ROI over the long term, so to say whereas that would obviously trigger short-term negative NAV revisions for Kinnevik. But can you just help us understand your view with regards to that trade-off?
Joachim, it's Samuel. I just think -- I mean, we've seen this a couple of times now, and we keep talking about the risk of down rounds. So I think sort of 2 of those words are a bit misguided, right? And I think you're alluding to one of them. We've corrected the fair values quite a lot in Q1 and in Q2. So it's a matter of down round to what, right? We're clearly below a number of sort of valuations that were underpinned by transactions. There might be down rounds in relation to those sort of headline valuations, but we find it sort of unlikely, at least today, that there will be down rounds in relation to our NAV. And as Georgi sort of was going to say, there's not really a risk here, it's more an opportunity. Georgi?
Yes, exactly, Samuel. But I think I understand what you're alluding to. And yes, there are, of course, opportunities for us to invest more into companies when they are valued lower. And we think about the kind of mid, long-term performance of this business and the total shareholder return, which seems the right thing to do as a long-term investment company. Therefore, when we see a company that we are excited about, independently if it's in our portfolio or in the market, we will invest.
And as we have no further questions from the phones at this time, I'll hand the floor back to our speakers.
Thank you very much for your questions and for listening. And again, we are very sorry about the audio quality issues we've had. Hopefully, we change our microphones in the room so maybe you heard us during the Q&A session when we answered or on the webcast. But as a last reminder, we will report our results for the third quarter of 2022 on the 19th of October. Until then, have a great summer. Thank you.